🇺🇸 FDA
Patent

US 9884104

Live attenuated virus vaccines for la crosse virus and other bunyaviridae

granted A61KA61K2039/5252A61K2039/5254

Quick answer

US patent 9884104 (Live attenuated virus vaccines for la crosse virus and other bunyaviridae) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/5252, A61K2039/5254, A61K39/00, A61K39/12